Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-04, Stock:JNJ, The news for the past five days is as follows:
2018-04-27: NEWS1: Biotech Stocks Facing FDA Decision In May.NEWS2: Biotech Stocks Facing FDA Decision In May.NEWS3: GlaxoSmithKline’s 1Q18 Earnings: Performance by Segment.NEWS4: Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales.NEWS5: Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales.NEWS6: Allergan’s 1Q18 Estimates: Expect Growth in Revenues.NEWS7: Daily Chatter: Trillion Dollar Babies.
2018-04-30: NEWS1: 8 Dividend Aristocrats That Also Offer Stock Price Growth.NEWS2: 8 Dividend Aristocrats That Also Offer Stock Price Growth.NEWS3: Exxon Mobil Corporation Leads 6 Dividend Stocks Boosting Payouts.NEWS4: Exxon Mobil Corporation Leads 6 Dividend Stocks Boosting Payouts.NEWS5: 3 Top Value Stocks to Buy Right Now.NEWS6: 3 Top Value Stocks to Buy Right Now.NEWS7: Johnson & Johnson Facing 3 Important Risks in Coming Year.NEWS8: Johnson & Johnson Facing 3 Important Risks in Coming Year.NEWS9: 3 Top Value Stocks to Buy Right Now.NEWS10: Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings.NEWS11: Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings.NEWS12: Why Analysts Expect Pfizer to See Revenue Growth in 1Q18.NEWS13: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS14: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS15: What Analysts Expect for Pfizer in 1Q18.NEWS16: Eliquis and Xeljanz: Key Growth Drivers for Pfizer in 2018.NEWS17: Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918.NEWS18: Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918.
2018-05-01: NEWS1: Pfizer Reports 1Q18 Earnings and Revenue Growth.NEWS2: Merck & Co.’s 1Q18 Earnings: Revenues up 6%.NEWS3: Merck (MRK) Beats on Q1 Earnings, Lags Sales, Raises Outlook.NEWS4: Merck (MRK) Beats on Q1 Earnings, Lags Sales, Raises Outlook.NEWS5: Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat.NEWS6: Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat.NEWS7: 3 Dividend Stocks That Are Minting Money.NEWS8: 3 Dividend Stocks That Are Minting Money.NEWS9: 3 Dividend Stocks That Are Minting Money.
2018-05-02: NEWS1: Close Update: Wall Street Loses Grip as Inflation Estimates Spook Market.NEWS2: Close Update: Wall Street Loses Grip as Inflation Estimates Spook Market.NEWS3: Janssen Biotech&apos;s proposed purchase of a Maryland biopharm firm could top $1B.NEWS4: 4 Stocks Poised to Fall as the Dollar Rebounds.NEWS5: Midday Update: Wall Street Braces for FOMC Outlook on Inflation.NEWS6: Midday Update: Wall Street Braces for FOMC Outlook on Inflation.NEWS7: Janssen Biotech signs deal to buy Maryland immunotherapy company.NEWS8: Johnson & Johnson to Host Consumer and Medical Devices Business Review.NEWS9: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS10: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS11: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).
2018-05-03: NEWS1: How Johnson & Johnson’s Medical Device Segment Did in 1Q18.NEWS2: Johnson & Johnson’s Financial Performance.NEWS3: How Johnson & Johnson’s Key Therapeutic Products Have Performed.NEWS4: How Johnson & Johnson’s Pharmaceutical Segment Has Performed.NEWS5: How Much Upside Analysts See in Johnson & Johnson Stock.NEWS6: Analyzing Johnson & Johnson’s Geographic Performance.NEWS7: [$$] The Fact Is the Hip Replacements Were Bad.NEWS8: Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference.NEWS9: What's in the Cards for Geron (GERN) This Earnings Season?.NEWS10: What's in the Cards for Geron (GERN) This Earnings Season?.NEWS11: What&apos;s in the Cards for Geron (GERN) This Earnings Season?.NEWS12: Cardinal Health Lowers FY18 Adj. EPS Guidance - Quick Facts.NEWS13: Cardinal Health Lowers FY18 Adj. EPS Guidance - Quick Facts.

Answer: Rise